We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Department of Pathology - Division of Genomic and Molecular Pathology

Clifford Harding, MD, PhD, Department Chair - 216-368-3611

Navid Sadri, MD, PhD, Division Chief, Genomic and Molecular Pathology - 216-286-4286
Adam Baldwin, Vice President - 216-844-5678

Please call 216-844-LABS (5227).

This state-of-the-art molecular diagnostics program integrates multiple laboratories, enabling integrative multiplatform testing and comprehensive result reporting. Capacities include extensive traditional and next-generation sequencing technologies, karyotyping, microarray, fluorescence in situ hybridization, and PCR-based assays.

Distinguishing Features

  • Identification of diagnostic, prognostic, and therapeutic molecular oncology biomarkers to guide targeted therapy
  • Carrier screening and diagnosis of key constitutional developmental, metabolic, and thrombotic disorders
  • Genotyping of infectious organisms, like HIV and H. pylori, to guide optimal therapy regimens
  • Support and design of collaborative clinical research initiatives
  • Expert consultation available for test ordering and interpretation